Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Schering-Plough develops dual PAF and histamine antagonist

Jan. 16, 1997

New antihistamines in the pipeline at HMR

Jan. 16, 1997

Inhale/Centeon agreement for alpha1-proteinase inhibitor

Jan. 15, 1997

FDA proposes withdrawal of terfenadine products

Jan. 15, 1997

New PDE IV/TNF inhibitors from Chiroscience

Jan. 15, 1997

PDE IV inhibitors revealed by Byk Gulden

Jan. 15, 1997

Ventus progressing well in phase III

Jan. 13, 1997

Bio-Technology General's OxSODrol tested for safety and efficacy

Jan. 13, 1997

French investigators announce success of gene therapy for CF

Jan. 13, 1997

Dual TNF/PDE IV inhibitors described by Chiroscience

Jan. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...